Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

CPH.TO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Cipher Pharmaceuticals Inc.TSX: CPH.TO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) dips below year-ago levels

Q1 FY2026 weighted avg shares (diluted) of 25.8M shares fell 1.5% year over year, behind the +3.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.1% from the prior quarter. Over 3 fiscal years it compounded at +0.5% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -1.5% toward the trailing-twelve-month pace of +3.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
25.8M-1.1% QoQ
Last fiscal yearDec 2025
25.99M+5.8% YoY
LTMMar 2026
26.09M+3.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.5%——
1 year+5.8%——
3-year CAGR+0.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
25.99M USD
Year-over-year change
+5.8%
4-year CAGR
-0.8%

Weighted Avg Shares (Diluted) vs competitors

How CPH.TO compares with its peers on the latest reported figures

  • CPH.TO's LTM Mar 2026 weighted avg shares (diluted) of 26.09M shares is the lowest of the 8 companies compared; the peer median is 134.1M shares.
  • Its year-over-year change of +3.3% is the 6th highest of 8, against a peer median of +4.7%.
  • Over three fiscal years its annual growth of +0.5% compares with a peer median of +5.0%.
CPH.TO Competitors Peer median
Weighted Avg Shares (Diluted) for CPH.TO and competitors
Company Period LTM YoY 3-year CAGR
TSND.TOTerrAscend Corp.LTM Mar 2026305.61M +4.7%+7.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026289.2M +2.4%+2.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026288.35M +167.7%+8.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026134.1M +15.6%—
GUD.TOKnight Therapeutics Inc.LTM Mar 202699.35M -1.6%-4.7%
ACB.TOAurora Cannabis Inc.LTM Mar 202656.7M +3.3%+20.7%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202630.57M +11.5%+2.8%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202626.09M +3.3%+0.5%
Peer median (excluding CPH.TO) 134.1M+4.7%+5.0%

Competitors are the stored peer set for CPH.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue21.94M20.68M21.16M33.36M51.33M
Cost of Revenue3.68M3.99M4.07M9.26M17.56M
Gross Profit18.26M16.68M17.09M24.1M33.77M
Gross Margin83.2%80.7%80.8%72.2%65.8%
Research & Development88K98K139K021.37K
Selling, General & Admin5.11M4.4M5.43M12.24M16.3M
Operating Expenses6.45M5.63M5.56M16.26M16.97M
Depreciation & Amortization701K989K1.23M4.02M7.23M
EBITDA13.66M12.04M11.53M11.87M24.1M
EBITDA Margin62.2%58.2%54.5%35.6%46.9%
Operating Income11.82M12.04M11.53M7.85M16.8M
Operating Margin53.9%58.2%54.5%23.5%32.7%
Interest Income12K464K1.87M330K0
Interest Expense92K0001.19M
Other Income / Expenses(2M)(560K)1.15M(4.89M)661.38K
Income Before Tax11.06M11.48M12.68M2.96M17.46M
Pre-Tax Margin50.4%55.5%59.9%8.9%34.0%
Income Tax Expense3.3M(15.16M)(7.7M)(8.59M)(10.34M)
Net Income7.76M26.64M20.38M11.55M27.81M
Net Margin35.4%128.8%96.3%34.6%54.2%
EPS (Basic)0.291.060.800.471.09
EPS (Diluted)0.291.040.800.471.07
Weighted Avg Shares26.6M25.13M25.48M24.72M25.48M
Weighted Avg Shares (Diluted)26.83M25.59M25.42M24.57M25.99M

Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Intrinsic Alpha fair value

Locked

Current Price

$13.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.